{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:55:12Z","timestamp":1793037312211,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/AA\/2023-5582"],"award-info":[{"award-number":["EMDR\/SG\/AA\/2023-5582"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.102922","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:58:37Z","timestamp":1760695117000},"page":"102922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["CRISPR\/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects"],"prefix":"10.1016","volume":"113","author":[{"given":"Kalpana","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3762-7574","authenticated-orcid":false,"given":"Devendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102922_bib1","unstructured":"A Phase 2, 2022b. Double-blind, Randomized, Active-controlled Evaluation of the Safety, Tolerability, Pharmacokinetics and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug Resistant E. Coli, in: Parexel (Ed.)."},{"key":"10.1016\/j.arr.2025.102922_bib2","unstructured":"A Phase I, 2016. Clinical Trial of PD-1 Knockout Engineered T Cells Treating Patients With Advanced Non-small Cell Lung Cancer, in: Chengdu MedGenCell, C.L. (Ed.)."},{"key":"10.1016\/j.arr.2025.102922_bib3","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/hmg\/ddaa106","article-title":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR\/Cas9 genome editing using homology-directed repair","volume":"29","author":"Ababneh","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2025.102922_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102922_bib5","first-page":"16","article-title":"CRISPR in neurodegenerative diseases treatment: an alternative approach to current therapies","author":"Akbar","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.arr.2025.102922_bib6","doi-asserted-by":"crossref","first-page":"47504","DOI":"10.1021\/acsomega.2c05609","article-title":"Preclinical models for Alzheimer\u2019s disease: past, present, and future approaches","volume":"7","author":"Akhtar","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2025.102922_bib7","article-title":"Principles of CRISPR-Cas9 technology: advancements in genome editing and emerging trends in drug delivery","volume":"92","author":"Aljabali","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102922_bib8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s12035-022-03150-5","article-title":"CRISPR\/Cas9 mediated therapeutic approach in huntington's disease","volume":"60","author":"Alkanli","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102922_bib9","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.3390\/ijms24087052","article-title":"Recent advances in Genome-Editing technology with CRISPR\/Cas9 variants and Stimuli-Responsive targeting approaches within tumor cells: a future perspective of cancer management","volume":"24","author":"Allemailem","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib10","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2025.5748","article-title":"Current updates on the structural and functional aspects of the CRISPR\/Cas13 system for RNA targeting and editing: a next\u2011generation tool for cancer management (Review)","volume":"66","author":"Allemailem","year":"2025","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.arr.2025.102922_bib11","unstructured":"An Open-label, 2022a. First-in-Human Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With Type 1 Diabetes Mellitus (T1D), in: ViaCyte (Ed.)."},{"key":"10.1016\/j.arr.2025.102922_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature13579","article-title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease","volume":"513","author":"Anders","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102922_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.freeradbiomed.2019.06.007","article-title":"Interrogating parkinson's disease associated redox targets: potential application of CRISPR editing","volume":"144","author":"Artyukhova","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2025.102922_bib14","first-page":"353","article-title":"Mechanism and applications of CRISPR\/Cas-9-Mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.arr.2025.102922_bib15","first-page":"21","article-title":"Recent advancements in reducing the Off-Target effect of CRISPR-Cas9 genome editing","volume":"18","author":"Asmamaw Mengstie","year":"2024","journal-title":"Biologics"},{"key":"10.1016\/j.arr.2025.102922_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3906\/biy-1912-52","article-title":"Bioethical issues in genome editing by CRISPR-Cas9 technology","volume":"44","author":"Ayanoglu","year":"2020","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2024.1509924","article-title":"Advances in CRISPR-Cas technology and its applications: revolutionising precision Medicine","volume":"6","author":"Azeez","year":"2024","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.arr.2025.102922_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymthe.2023.11.013","article-title":"Recent application of CRISPR-Cas12 and OMEGA system for genome editing","volume":"32","author":"Badon","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.arr.2025.102922_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.molcel.2014.03.011","article-title":"CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity","volume":"54","author":"Barrangou","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2025.102922_bib20","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2025.102922_bib21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.ymthe.2023.03.024","article-title":"CRISPR-Cas-mediated transcriptional modulation: the therapeutic promises of CRISPRa and CRISPRi","volume":"31","author":"Bendixen","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.arr.2025.102922_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12033-021-00422-8","article-title":"CRISPR\/Cas-Based modifications for therapeutic applications: a review","volume":"64","author":"Bharathkumar","year":"2022","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102457","article-title":"Advanced delivery systems for gene editing: a comprehensive review from the GenE-HumDi COST action working group","volume":"36","author":"Cavazza","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib24","article-title":"Recent advances of CRISPR-based genome editing for enhancing staple crops","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.arr.2025.102922_bib25","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1093\/nar\/gkae324","article-title":"Molecular mechanism for target RNA recognition and cleavage of Cas13h","volume":"52","author":"Chen","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2025.102922_bib26","unstructured":"Cohrt, K.O.H., 2024. Locus Biosciences Shares Positive Phase 2 Data for CRISPR-Edited Phage Treatment for Urinary Tract Infections. CRISPR NEWS MEDICINE."},{"key":"10.1016\/j.arr.2025.102922_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-med-112717-094629","article-title":"Ethics of human genome editing","volume":"70","author":"Coller","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.arr.2025.102922_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102922_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fnmol.2019.00110","article-title":"Editing the central nervous system through CRISPR\/Cas9 systems","volume":"12","author":"Cota-Coronado","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnins.2024.1422442","article-title":"Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances","volume":"18","author":"Cui","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1422442","article-title":"Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances","volume":"18","author":"Cui","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib32","article-title":"The CRISPR therapy: a revolutionary breakthrough in genetic Medicine","author":"da Silva Barreto","year":"2022","journal-title":"Int. Healthc. Rev. (Online)"},{"key":"10.1016\/j.arr.2025.102922_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158714","article-title":"Applications of CRISPR-Cas9 in alzheimer's disease and related disorders","volume":"23","author":"De Plano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tibtech.2024.12.006","article-title":"Human health and genetic technology","volume":"43","author":"Dederer","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib35","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1093\/nar\/gki912","article-title":"Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells","volume":"33","author":"Durai","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2025.102922_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-Mediated genome editing increases lifespan and improves motor deficits in a huntington's disease mouse model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031832","article-title":"CRISPR therapeutics for duchenne muscular dystrophy","volume":"23","author":"Erkut","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102317","article-title":"Cas9 editing of ATXN1 in a spinocerebellar ataxia type 1 mice and human iPSC-derived neurons","volume":"35","author":"Fagan","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmb.2018.08.030","article-title":"CRISPR\u2013Cas: complex functional networks and multiple roles beyond adaptive immunity","volume":"431","author":"Faure","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-05531-1","article-title":"Non-viral precision t\u2009cell receptor replacement for personalized cell therapy","volume":"615","author":"Foy","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102922_bib41","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/j.jtct.2023.12.312","article-title":"AsCas12a gene editing of HBG1\/2 promoters with Edit-301 results in early and sustained normalization of hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease and Transfusion-Dependent Beta-Thalassemia","volume":"30","author":"Frangoul","year":"2024","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.arr.2025.102922_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib43","unstructured":"Genetic Alliance, 2025. The New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services. Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals."},{"key":"10.1016\/j.arr.2025.102922_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.657981","article-title":"The challenge of CRISPR-Cas toward bioethics","volume":"12","author":"Gonzalez-Avila","year":"2021","journal-title":"Front. Microbiol"},{"key":"10.1016\/j.arr.2025.102922_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012188","article-title":"Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in parkinson's disease","volume":"13","author":"Guhathakurta","year":"2021","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.arr.2025.102922_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086894","article-title":"RNA-Dependent RNA targeting by CRISPR-Cas systems: characterizations and applications","volume":"24","author":"Gunitseva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib48","first-page":"28","article-title":"From the clinic TO BIOTECH: how vertex hopes to transform the treatment landscape for type 1 diabetes","author":"Gupta","year":"2023","journal-title":"Endocr. N."},{"key":"10.1016\/j.arr.2025.102922_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116636","article-title":"CRISPR-Cas9 system: a new-fangled Dawn in gene editing","volume":"232","author":"Gupta","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2025.102922_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for Early-Onset alzheimer's disease","volume":"11","author":"Gyorgy","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib51","doi-asserted-by":"crossref","unstructured":"Hamdan, M.F., Tan, B.C., 2024. Genetic modification techniques in plant breeding: A comparative review of CRISPR\/Cas and GM technologies. Horticultural Plant Journal.","DOI":"10.1016\/j.hpj.2024.02.012"},{"key":"10.1016\/j.arr.2025.102922_bib52","unstructured":"Hathaway, B., 2025. New CRISPR tool enables more seamless gene editing \u2014 and improved disease modeling. YaleNews."},{"key":"10.1016\/j.arr.2025.102922_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-020-00283-8","article-title":"The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer","volume":"5","author":"He","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2025.102922_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2025.1612868","article-title":"Stem cell and CRISPR\/Cas9 gene editing technology in alzheimer's disease therapy: from basic research to clinical innovation","volume":"7","author":"He","year":"2025","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.arr.2025.102922_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41398-021-01605-2","article-title":"CRISPR\/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells","volume":"11","author":"He","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.102922_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/genes14040850","article-title":"The CRISPR\/Cas system: a customizable toolbox for molecular detection","volume":"14","author":"He","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.arr.2025.102922_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A review on the mechanism and applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 proteins utilized for genome engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib59","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/bioinformatics\/btaa041","article-title":"Generalizable sgRNA design for improved CRISPR\/Cas9 editing efficiency","volume":"36","author":"Hiranniramol","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.arr.2025.102922_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1011399","article-title":"CRISPR-Cas13: a new technology for the rapid detection of pathogenic microorganisms","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.arr.2025.102922_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123756","article-title":"A targeted approach: gene and RNA editing for neurodegenerative disease treatment","volume":"376","author":"Huang","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2025.102922_bib62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","article-title":"Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells","volume":"142","author":"Hunt","year":"2023","journal-title":"Hum. Genet."},{"key":"10.1016\/j.arr.2025.102922_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13059-020-02193-y","article-title":"A versatile toolkit for CRISPR-Cas13-based RNA manipulation in drosophila","volume":"21","author":"Huynh","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.arr.2025.102922_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00580-17","article-title":"History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology","volume":"200","author":"Ishino","year":"2018","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.arr.2025.102922_bib65","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","article-title":"APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of alzheimer disease","volume":"32","author":"Jackson","year":"2024","journal-title":"Mol Ther J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.arr.2025.102922_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl0164","article-title":"tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector","volume":"10","author":"Jain","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2025.102922_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249604","article-title":"Various aspects of a gene editing System-CRISPR-Cas9","volume":"21","author":"Janik","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.761709","article-title":"CRISPR\/Cas system and factors affecting its precision and efficiency","volume":"9","author":"Javaid","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib69","series-title":"Verve Therapeutics","first-page":"1","article-title":"Verve therapeutics announces positive initial data from the Heart-2 phase 1b clinical trial of VERVE-102, an in vivo base editing Medicine targeting PCSK9","author":"Jen Robinson Verve Therapeutics","year":"2025"},{"key":"10.1016\/j.arr.2025.102922_bib70","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s12035-018-1218-2","article-title":"Pathological modification of TDP-43 in amyotrophic lateral sclerosis with SOD1 mutations","volume":"56","author":"Jeon","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102922_bib71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","article-title":"DNA repair deficiency in neurodegeneration","volume":"94","author":"Jeppesen","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102922_bib72","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.gendis.2023.03.017","article-title":"CRISPR\/Cas9 system and its applications in nervous system diseases","volume":"11","author":"Jiang","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.arr.2025.102922_bib73","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102922_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","article-title":"CRISPR-based diagnostics","volume":"5","author":"Kaminski","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.arr.2025.102922_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA Base-Editing and Prime-Editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417320","article-title":"Challenges of CRISPR\/Cas-Based cell therapy for type 1 diabetes: how not to engineer a \"trojan horse\"","volume":"24","author":"Karpov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-024-55550-x","article-title":"Dual-targeting CRISPR-CasRx reduces C9orf72 ALS\/FTD sense and antisense repeat RNAs in vitro and in vivo","volume":"16","author":"Kempthorne","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102922_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104682","article-title":"AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice","volume":"93","author":"Keng","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.arr.2025.102922_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/genes11080921","article-title":"CRISPR\/Cas9 in cancer immunotherapy: animal models and human clinical trials","volume":"11","author":"Khalaf","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.arr.2025.102922_bib80","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s12276-025-01462-9","article-title":"Revolutionizing CRISPR technology with artificial intelligence","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.arr.2025.102922_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0044-1785234","article-title":"CRISPR-Cas9 gene editing: curing genetic diseases by inherited epigenetic modifications","volume":"11","author":"Kolanu","year":"2024","journal-title":"Glob. Med Genet"},{"key":"10.1016\/j.arr.2025.102922_bib82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.omtn.2019.07.004","article-title":"Suppression of mutant protein expression in SCA3 and SCA1 mice using a CAG Repeat-Targeting antisense oligonucleotide","volume":"17","author":"Kourkouta","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2024.102496","article-title":"Regulation of pathway choice in DNA repair after double-strand breaks","volume":"80","author":"Kumari","year":"2025","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.arr.2025.102922_bib84","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tibs.2022.02.004","article-title":"Creating memories: molecular mechanisms of CRISPR adaptation","volume":"47","author":"Lee","year":"2022","journal-title":"Trends Biochem Sci."},{"issue":"1","key":"10.1016\/j.arr.2025.102922_bib85","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2025.102922_bib86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2025.102922_bib87","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","article-title":"CRISPR\/Cas9-mediated gene editing in human tripronuclear zygotes","volume":"6","author":"Liang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.arr.2025.102922_bib88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-genet-071719-022559","article-title":"The tracrRNA in CRISPR biology and technologies","volume":"55","author":"Liao","year":"2021","journal-title":"Annu Rev. Genet."},{"key":"10.1016\/j.arr.2025.102922_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102344","article-title":"CRISPR-Cas9-mediated homology-directed repair for precise gene editing","volume":"35","author":"Liao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib90","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/pcmedi\/pbab014","article-title":"Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics","volume":"4","author":"Liu","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.arr.2025.102922_bib91","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited t cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102922_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.803894","article-title":"Application of CRISPR\/Cas9 in alzheimer's disease","volume":"15","author":"Lu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902312","article-title":"CRISPR\/Cas systems in genome editing: methodologies and tools for sgRNA design, Off-Target evaluation, and strategies to mitigate Off-Target effects","volume":"7","author":"Manghwar","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102114","article-title":"Exploring Parkinson-associated kinases for CRISPR\/Cas9-based gene editing: beyond alpha-synuclein","volume":"92","author":"Mansour","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102922_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.880030","article-title":"Application of CRISPR\/Cas genomic editing tools for HIV therapy: toward precise modifications and multilevel protection","volume":"12","author":"Maslennikova","year":"2022","journal-title":"Front. Cell Infect. Microbiol"},{"key":"10.1016\/j.arr.2025.102922_bib96","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ydbio.2018.10.008","article-title":"Mosaicism in CRISPR\/Cas9-mediated genome editing","volume":"445","author":"Mehravar","year":"2019","journal-title":"Dev. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.644319","article-title":"Delivery platforms for CRISPR\/Cas9 genome editing of glial cells in the central nervous system","volume":"3","author":"Meneghini","year":"2021","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.arr.2025.102922_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102851","article-title":"Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"111","author":"Meshram","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102922_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102377","article-title":"CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1","volume":"35","author":"Micl\u0103u\u0219","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2025.102922_bib100","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1042\/BCJ20180248","article-title":"The parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated rab protein phosphorylation in mouse and human","volume":"475","author":"Mir","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2025.102922_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/bs.pmbts.2024.07.017","article-title":"Recent progress in CRISPR-Cas-system for neurological disorders","volume":"210","author":"Mishra","year":"2025","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41593-022-01207-1","article-title":"An RNA-targeting CRISPR\u2013Cas13d system alleviates disease-related phenotypes in Huntington\u2019s disease models","volume":"26","author":"Morelli","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib103","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1038\/ncomms6560","article-title":"Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9","volume":"5","author":"Nakade","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102922_bib104","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41589-022-01082-8","article-title":"CRISPR-Cas12a-mediated DNA clamping triggers target-strand cleavage","volume":"18","author":"Naqvi","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib105","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/encyclopedia3040096","article-title":"Gene editing: the regulatory perspective","volume":"3","author":"Niazi","year":"2023","journal-title":"Encyclopedia"},{"key":"10.1016\/j.arr.2025.102922_bib106","unstructured":"Open-label, 2023. Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients with Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol."},{"key":"10.1016\/j.arr.2025.102922_bib107","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944204","article-title":"Editorial: first regulatory approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and Transfusion-Dependent \u03b2-Thalassemia","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci. Monit."},{"key":"10.1016\/j.arr.2025.102922_bib108","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1093\/nar\/gkab1272","article-title":"Mechanics of CRISPR-Cas12a and engineered variants on \u03bb-DNA","volume":"50","author":"Paul","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2025.102922_bib109","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1093\/nar\/gkab1272","article-title":"Mechanics of CRISPR-Cas12a and engineered variants on \u03bb-DNA","volume":"50","author":"Paul","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2025.102922_bib110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bj.2019.10.005","article-title":"CRISPR-Cas12a: functional overview and applications","volume":"43","author":"Paul","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.arr.2025.102922_bib111","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias - from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2010.05765.x","article-title":"The role of gene expression in ecological speciation","volume":"1206","author":"Pavey","year":"2010","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib113","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.102922_bib114","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40824-023-00381-y","article-title":"CRISPR\/Cas9 assisted stem cell therapy in parkinson's disease","volume":"27","author":"Pinjala","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.arr.2025.102922_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1711023115","article-title":"Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy","volume":"115","author":"Potting","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2025.102922_bib116","article-title":"AI sheds new light on genome editing","author":"Qin","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib117","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12264-022-00880-3","article-title":"CRISPR-Based Genome-Editing tools for huntington's disease research and therapy","volume":"38","author":"Qin","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.arr.2025.102922_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1223747","article-title":"Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of parkinson's disease","volume":"17","author":"Qu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib119","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/hum.2011.087","article-title":"Zinc-finger nucleases for somatic gene therapy: the next frontier","volume":"22","author":"Rahman","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.arr.2025.102922_bib120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/archdischild-2016-310459","article-title":"What is CRISPR\/Cas9?","volume":"101","author":"Redman","year":"2016","journal-title":"Arch. Dis. Child Educ. Pr. Ed."},{"key":"10.1016\/j.arr.2025.102922_bib121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"R\u00fcb","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102922_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100344","article-title":"CRISPR cas systems: from bacterial defense mechanisms to revolutionary tools reshaping genetic research and translation therapeutics","volume":"7","author":"Saeed","year":"2025","journal-title":"Microbe"},{"key":"10.1016\/j.arr.2025.102922_bib123","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamaneurol.2023.4983","article-title":"Building CRISPR gene therapies for the central nervous system: a review","volume":"81","author":"Salomonsson","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102922_bib124","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fanim.2024.1368155","article-title":"Tackling mosaicism in gene edited livestock","volume":"5","author":"Salvesen","year":"2024","journal-title":"Front. Anim. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071037","article-title":"Gene suppression therapies in hereditary cerebellar ataxias: a systematic review of animal studies","volume":"12","author":"Santos","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arr.2025.102922_bib126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ID9.0000000000000149","article-title":"Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogens","volume":"5","author":"Selim","year":"2025","journal-title":"Infect. Dis. Immun."},{"key":"10.1016\/j.arr.2025.102922_bib127","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s42003-023-04829-8","article-title":"DNA double-strand break-free CRISPR interference delays Huntington\u2019s disease progression in mice","volume":"6","author":"Seo","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tibs.2015.08.006","article-title":"Microhomology-Mediated end joining: a Back-up survival mechanism or dedicated pathway?","volume":"40","author":"Sfeir","year":"2015","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.arr.2025.102922_bib129","series-title":"Applications of Genome Modulation and Editing","first-page":"29","article-title":"Tools for efficient genome editing; ZFN, TALEN, and CRISPR","author":"Shamshirgaran","year":"2022"},{"key":"10.1016\/j.arr.2025.102922_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2024.2351657","article-title":"Programmable RNA targeting with CRISPR-Cas13","volume":"21","author":"Shi","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.arr.2025.102922_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1223777","article-title":"CRISPR\/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis","volume":"17","author":"Shi","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102922_bib132","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21775\/cimb.026.103","article-title":"Ethical issues regarding CRISPR mediated genome editing","author":"Shinwari","year":"2018","journal-title":"Curr. Issues Mol. Biol. 26"},{"key":"10.1016\/j.arr.2025.102922_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115992","article-title":"Improving Homology-Directed repair in genome editing experiments by influencing the cell cycle","volume":"23","author":"Smirnikhina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib134","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102922_bib135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA Double-Strand breaks by the nonhomologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2025.102922_bib136","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2105\/AJPH.2023.307315","article-title":"CRISPR in public health: the health equity implications and role of community in Gene-Editing research and applications","volume":"113","author":"Subica","year":"2023","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.arr.2025.102922_bib137","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1016\/j.celrep.2017.11.100","article-title":"RNA-Independent DNA cleavage activities of Cas9 and Cas12a","volume":"21","author":"Sundaresan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2025.102922_bib138","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.102922_bib139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-020-00402-7","article-title":"The alzheimer's disease-associated protective Plc\u03b32-P522R variant promotes immune functions","volume":"15","author":"Takalo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102922_bib140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.celrep.2018.06.105","article-title":"RNA binding and HEPN-Nuclease activation are decoupled in CRISPR-Cas13a","volume":"24","author":"Tambe","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2025.102922_bib141","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.7150\/ijms.112724","article-title":"Overcoming the delivery challenges in CRISPR\/Cas9 gene editing for effective cancer treatment: a review of delivery systems","volume":"22","author":"Tang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073845","article-title":"Huntington's disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuae020","article-title":"The rise and future of CRISPR-based approaches for high-throughput genomics","volume":"48","author":"Vercauteren","year":"2024","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.arr.2025.102922_bib144","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0378-1119(88)90212-0","article-title":"A new revision of the sequence of plasmid pBR322","volume":"70","author":"Watson","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.arr.2025.102922_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00424-020-02497-9","article-title":"Nobel Prize 2020 in chemistry honors CRISPR: a tool for rewriting the code of life","volume":"473","author":"Westermann","year":"2021","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.arr.2025.102922_bib146","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3934\/microbiol.2023040","article-title":"Type I CRISPR-Cas-mediated microbial gene editing and regulation","volume":"9","author":"Xu","year":"2023","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.arr.2025.102922_bib147","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","article-title":"CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy","volume":"18","author":"Xu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.arr.2025.102922_bib148","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41589-024-01593-6","article-title":"Structures, mechanisms and applications of RNA-centric CRISPR-Cas13","volume":"20","author":"Yang","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2025.102922_bib149","article-title":"Methods favoring Homology-Directed repair choice in response to CRISPR\/Cas9 Induced-Double strand breaks","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117557","article-title":"An insight into allele-selective approaches to lowering mutant huntingtin protein for Huntington\u2019s disease treatment","volume":"180","author":"Yao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.102922_bib151","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.synbio.2018.09.004","article-title":"CRISPR-Cas9\/Cas12a biotechnology and application in bacteria","volume":"3","author":"Yao","year":"2018","journal-title":"Synth. Syst. Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113801","article-title":"CRISPR\/Cas9-Mediated gene correction to understand ALS","volume":"21","author":"Yun","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102922_bib153","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymeth.2021.04.023","article-title":"Alleviation of neurological disease by RNA editing","volume":"194","author":"Zhang","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.arr.2025.102922_bib154","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.molcel.2013.05.001","article-title":"Processing-Independent CRISPR RNAs limit natural transformation in neisseria meningitidis","volume":"50","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2025.102922_bib155","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/pbi.13383","article-title":"Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective","volume":"18","author":"Zhang","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.arr.2025.102922_bib156","article-title":"Advances in application of CRISPR-Cas13a system","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.arr.2025.102922_bib157","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.arr.2025.102922_bib158","doi-asserted-by":"crossref","DOI":"10.34133\/bdr.0041","article-title":"CRISPR-Cas13: pioneering RNA editing for nucleic acid therapeutics","volume":"6","author":"Zhu","year":"2024","journal-title":"Biodesign Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:59:22Z","timestamp":1778821162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":158,"alternative-id":["S1568163725002685"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102922","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102922"}}